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Abstract 
Background: The decline of remyelination in chronic multiple sclerosis (MS) is in part attributed to inadequate 
oligodendrocyte precursor cell (OPC) migration, a process governed by the extracellular matrix (ECM). Elucidating the 
mechanisms underlying OPC migration is therefore an important step towards developing new therapeutic strate‑
gies to promote myelin repair. Many seminal OPC culture methods were established using rat‑sourced cells, and these 
often need modification for use with mouse OPCs due to their sensitive nature. It is of interest to develop mouse OPC 
assays to leverage the abundant transgenic lines. To this end, we developed a new OPC migration method specifically 
suited for use with mouse‑derived cells.
Results: To validate its utility, we combined the new OPC migration assay with a conditional knockout approach to 
investigate the role of integrin‑linked kinase (ILK) in OPC migration. ILK is a focal adhesion protein that stabilizes cel‑
lular adhesions to the extracellular matrix (ECM) by mediating a linkage between matrix‑bound integrin receptors and 
the cytoskeleton. We identified ILK as a regulator of OPC migration on three permissive substrates. ILK loss produced 
an early, albeit transient, deficit in OPC migration on laminin matrix, while migration on fibronectin and polylysine was 
heavily reliant on ILK expression.
Conclusions: Inclusively, our work provides a new tool for studying mouse OPC migration and highlights the role of 
ILK in its regulation on ECM proteins relevant to MS.
Keywords: Mouse oligodendrocyte precursor cells, Migration, Integrin‑linked kinase, Extracellular matrix, Laminin, 
Fibronectin, Polylysine
© 2016 O’Meara et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Oligodendrocytes (OLs) are responsible for generating 
myelin, a lipid-rich structure that envelops central nerv-
ous system (CNS) axons, allowing for rapid communi-
cation between neurons. OLs generate myelin as they 
differentiate by extending multiple processes that con-
tact adjacent axons, forming concentric wrappings of 
lipid-rich OL membrane mostly devoid of cytoplasm and 
stabilized by myelin structural proteins [1]. Prior to the 
onset of myelination, newborn OL precursor cells (OPCs) 
undergo a transient period of local proliferation followed 
by migration [2], their direction and extent governed by 
patterning molecules. Proper myelination is therefore 
highly dependent on the capacity of OPCs to migrate to 
target destinations and initiate the differentiation pro-
gram. As such, researchers have endeavored to dissect 
the extracellular cues and the intracellular machinery 
governing OPC migration. This is especially relevant in 
neurological diseases like multiple sclerosis (MS) where 
the capacity for endogenous repair may be limited partly 
by the hampered migration of OPCs into lesions [3].
Over the years, our understanding of OL biology has 
vastly improved through the study of rat OLs in vitro, for 
which several isolation methods exist [4–6]. However, 
these strategies are often not ideal for isolating mouse 
OPCs for a number of reasons. First and foremost, mice 
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possess fewer OPCs due to their smaller size. Primary 
mouse OPCs are also more difficult to isolate when com-
pared to rat OPCs (reviewed by [7], and are less viable 
in  vitro [8]). As such, researchers have endeavored to 
modify existing rat OPC protocols/assays to allow for 
their use with mouse-derived cells [7, 9–11] to take advan-
tage of the broad spectrum of transgenic mouse lines.
We were interested in developing a mouse-optimized 
assay for studying OPC migration in  vitro. Tradition-
ally, OPC migration was typically assessed with the 
“transwell” or “agarose drop” assays [12]. The transwell 
assay [13] measures cell migration through a porous 
membrane, whereas the agarose drop assay [14] meas-
ures radial migration out of a drop of low-melting tem-
perature agarose. While effective with rat cells, certain 
aspects of these assays limit their applicability to mouse 
OPCs. In particular, the agarose drop assay calls for rela-
tively long assay durations (days), which does not appease 
the limited viability of mouse OPCs. Both protocols also 
call for large numbers of OPCs, which are laborious to 
obtain from mice, thereby fuelling us to devise a method 
for assessing mouse OPC migration that is rapid and 
requires few cells.
We previously established a protocol for isolating 
mouse OPCs [9], and as a byproduct of the procedure, 
OPCs tend to form aggregates (henceforth termed 
OPCAs) suspended in the culture media. We show that 
a highly enriched population of OPCs efficiently emerges 
from OPCAs, and describe a method to quantifiably 
assess this phenomenon. By combining the OPCA assay 
with conditional knockout genetics, we reveal a role for 
the focal adhesion protein integrin-linked kinase (ILK) 
in OPC migration on three substrates. Inclusively, we 
provide a new tool for the study of mouse OPC motility 
in vitro, and validate its utility through use in identifying 
ILK as a mediator of OPC migration.
Methods
Transgenic animals
Animals used for this work were cared for according to 
the Canadian Council on Animal Care guidelines under 
University of Ottawa Animal Care Committee protocol 
number OGH-130. The floxed Ilk mouse line (Ilkfl/fl; [15]) 
was graciously provided by Dr. René St-Arnaud (McGill 
University, Montreal, Canada). Ilkfl/fl mice were subse-
quently bred to homozygosity with the mT/mG reporter 
mouse strain [16] to yield the Ilkfl/fl; mT/mG line.
Cell culture
OPCAs were generated as a byproduct of the mouse 
OPC purification protocol previously described by us [9]. 
Neonatal mouse cortices were dissociated and seeded 
into poly-l-lysine coated T25 flasks in mixed glial culture 
media. Once cultures had achieved appropriate den-
sity, the flasks first underwent rotary shaking utilizing 
a VWR Advanced 3500 Orbital Shaker (0.75 inch orbit) 
at low speed (50  rpm) for 1 h to remove contaminating 
microglia. Fresh mixed culture media was added back 
to the cultures, which were then shaken at a speed of 
220 rpm overnight (approximately 16 h), to generate sus-
pended clumps of OPCs (OPCAs). The media was passed 
through a 40 µm cell strainer and the OPCAs were sub-
sequently backwashed onto sterile Petri dishes (Fig. 1a–
c). OPCAs were picked from the Petri dish with a P20 
pipette by aid of a stereomicroscope, and seeded indi-
vidually onto substrate-coated coverslips in migration or 
differentiation media (see below). Coverslips were coated 
with either human placental merosin (laminin; 10  µg/
mL; Millipore), fibronectin (50  µg/mL; Calbiochem) or 
>300,000 molecular weight poly-d-lysine (0.1  mg/mL; 
Sigma-Aldrich).
Cell culture media
Mixed glial culture media was Dulbecco’s modified eagle 
medium (DMEM) supplemented with 1  % GlutaMAX 
(Life Technologies), 10  % fetal bovine serum (FBS), 
0.33 % Penicillin–Streptomycin (P/S). From culture day 6 
and onwards, the mixed glial culture media was supple-
mented with 5 µg/mL insulin.
Migration media was composed of 48–72  h condi-
tioned mixed glial culture media (0.22 µm filtered), sup-
plemented with 2  % B27 (Gibco), 100  µg/mL bovine 
serum albumin (BSA), 5 µg/mL insulin, 0.5 µg/mL Holo-
transferrin, 60 ng/mL progesterone, 400 ng/mL 3,3′,5-tri-
iodo-l-thyronine, 400  ng/mL l-thyroxine, 16  µg/mL 
putrescine, 5  ng/mL sodium selenite, 10  ng/µL platelet-
derived growth factor (PDGF-AA; PeproTech), 50 ng/µL 
ciliary neurotrophic factor (CNTF; Peprotech) and 1 µg/
mL aphidicolin (Sigma-Aldrich).
Conditional genetic ablation
In vitro recombination of the Ilkfl/fl and mT/mG alleles 
was achieved by treating mixed glial cultures with recom-
binant His-TAT (trans-activator of transcription)-NLS 
(nuclear localization sequence)-Cre recombinase (hence-
forth called TAT-Cre; Excellgen Incorporated). Briefly, 
the media was removed and the cultures were washed 
with PBS. TAT-Cre (or the corresponding vehicle con-
trol) was administered at 10 µL/mL in DMEM with 2 % 
B27 and incubated on the cultures for 1–2 h. This treat-
ment was performed twice 48–72 h prior to OPCA isola-
tion to promote a high level of recombination.
Immunostaining and microscopy
OPCAs were fixed with 3 % paraformaldehyde (PFA) and 
then either processed for indirect immunofluorescence 
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microscopy, or mounted onto slides in DAKO medium 
after staining with Hoechst.
For indirect immunofluorescence, fixed OPCAs were 
permeabilized with 0.1  % Triton X-100 for 10  min at 
room temperature (RT), and washed with PBS. OPCAs 
were blocked with 10 % goat serum, and incubated over-
night at 4 °C with primary antibodies against Olig2 (EMD 
Millipore) or PDGFR-α (provided by Dr. William Stall-
cup, Sanford Burnham Medical Research Institute, La 
Jolla, California). The following day, the samples were 
washed with PBS and incubated with Alexa fluor-conju-
gated secondary antibodies (invitrogen) for 45 min to 1 h 
at RT. Coverslips were subsequently washed with PBS, 
counterstained with Hoechst and mounted onto slides in 
DAKO medium.
Standard epifluorescent images were acquired with 
an Axio Imager M1 microscope equipped with an Axi-
oCamHR HRm Rev.2 camera using EX Plan-Neofluar 
10x/0.3 Ph1 or Fluar 5x/0.25 M27 objectives and Axiovi-
sion 4.8.2 software. Confocal microscopy was conducted 
with a Zeiss LSM 510 Meta DuoScan microscope using 
EC Plan-Neofluar 10×/0.3 M27, 20×/0.5 M27, 40×/1.3 
Oil DIC M27 or Plan-Apochromat 63×/1.4 Oil DIC M27 
objectives and Zen 8.0 software.
Phase contrast microscopy was performed with an 
Axiovert 200  M microscope fitted with an AxioCamHR 
Fig. 1 Pictorial demonstration on how to obtain OPCAs from cell suspensions. a The cell suspension collected from shaken mixed glial cultures is 
gently added to a 40 µm cell strainer over a 50 mL conical tube. b The strainer is then flipped upside‑down and placed over a new 50 mL conical 
tube. c Migration media is used to backwash the strainer, causing the transfer of the OPCAs to the conical tube. d An image obtained through the 
eyepiece of a stereomicroscope, showing freshly isolated OPCAs. When selecting OPCAs for migration experiments, it is desirable to select those 
most uniform in dimension, such as the one denoted by the black arrow
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HRm Rev.2 camera using LD Plan Neofluar 20×/0.4 Korr 
Ph2 or EC Plan-Neofluar 10×/0.25 Ph1 objectives and 
Axiovision 4.6 software.
Migration quantification
Phase contrast images of OPCAs were acquired at time 
zero to record their original diameter. Migration assays 
were fixed at 4, 10 or 24  h and imaged by fluorescence 
microscopy. Using Photoshop, “exclusion zones” were 
digitally overlaid onto the residual OPCA core, serv-
ing to define the starting point of migration; only cells 
beyond the exclusion zone were considered to have truly 
migrated. For OPCAs seeded on laminin and fibronectin 
substrates, the size of the exclusion zone was 1.5 ×  the 
OPCA diameter at time zero. For the poly-d-lysine sub-
strate, the exclusion zone was 1.75×, 2.0× and 2.75× the 
time zero OPCA diameter for 4, 10 and 24 h time points, 
respectively.
Concentric rings were then digitally centered over the 
exclusion zone, their diameter increment being 50, 100 
and 200 µm for 4, 10 and 24 h time points for assays con-
ducted on laminin. For the fibronectin substrate, the ring 
diameter increment was 20, 40 and 80 µm for the 4, 10 
and 24 h time points, respectively. For the poly-d-lysine 
substrate, the ring increment for the 4, 10 and 24 h time 
points was 10, 20 and 40 µm, respectively. The number of 
OPCs that migrated to each concentric ring was quanti-
fied and represented as the percentage of OPCs in each 
ring. This can be considered a measure of migration dis-
tance or be represented as the total number of migrated 
OPCs, regardless of distance. We interpret this latter 
parameter as a function of the cell to initiate migration 
or polarize.
Immunoblot
Mixed glial cultures were cooled on ice for 3 min, rinsed 
with ice cold PBS, and scraped into a commercial RIPA 
lysis buffer (cell signaling) supplemented with 2  mM 
PMSF. Lysates were left on ice for approximately 2 min, 
and centrifuged at 15,000 rpm for 5 min. Clarified lysates 
were transferred to new microfuge tubes and stored at 
−80 °C.
For SDS-PAGE, 30  µg of cell lysate per sample was 
resolved on a poly-acrylamide gel, and transferred to a 
PDVF membrane at 0.25 amps for 70  min. Membranes 
were blocked for approximately 1 h at RT with 5 % skim 
milk power in TBST (10 mM Tris–HCl pH 8.0, 150 mM 
NaCl, 0.1  % Tween-20). Primary antibodies against ILK 
(cell signaling) and GAPDH (Abcam) were incubated 
overnight in blocking buffer. Membranes were washed 
with TBST and probed with HRP-conjugated second-
ary antibody for 45 min. Membranes were then washed 
with PBS, and treated with ECL (Thermo Scientific). 
Resulting films were scanned with an EPSON Perfec-
tion 2450 PHOTO scanner, imported into ImageJ, and a 
box of standard dimensions was placed over each band 
to measure the mean gray value. Densitometric values for 
ILK were normalized to GAPDH as a loading control.
Statistical analysis
One “n” (i.e., experiment) was considered as data 
obtained from pooled biological material (i.e., cells) 
from mouse pups (usually 4–6) of a distinct litter. Differ-
ences in migration distance were assessed using two-way 
repeated measures ANOVA paired with Bonferroni mul-
tiple comparisons tests. All other data was tested using 
either unpaired two-tailed Student’s t tests or one-way 
ANOVA paired with Bonferroni multiple comparisons 
tests. For all statistical tests, “n” was equal to or greater 
than three, and differences in the mean were considered 
significant when p < 0.05.
Results
An assay for investigating mouse OPC migration in vitro
In 1980, McCarthy and DeVellis published a seminal 
paper describing the isolation and propagation of pri-
mary rat OPCs in mixed glial cultures. In this method, 
neonatal cortical tissue is dissociated into a single cell 
suspension and seeded into tissue culture flasks. Over 
several days, astrocytes form a monolayer on the base 
of the flask, upon which OPCs proliferate. The OPCs 
are relatively loosely attached to this monolayer, and are 
susceptible to separation when flasks are shaken on an 
orbital rotator overnight at 37 °C. This procedure renders 
the suspension of OPCs in the culture medium, many of 
which form aggregates (OPCAs) due to their innate ten-
dency to do so [12].
In our mouse adaptation of the McCarthy and deVellis 
method [9], we took advantage of this aggregation phe-
nomenon to assess OPC migration. After the overnight 
shaking step, the medium containing the OPCAs was fil-
tered through a 40 μm cell strainer, and then backwashed 
with migration media into a 50 mL conical tube (Fig. 1a–
c). The backwashed media was then transferred to a Petri 
dish, and OPCAs were picked with a micropipette by aid 
of a stereomicroscope. As a result of the mechanism of 
their formation, OPCAs can be heterogeneous in shape, 
and care was taken in selecting the most uniform aggre-
gates for migration experiments (Fig. 1d).
Once selected, OPCAs were seeded individually onto 
substrate-coated coverslips in 48–72  h conditioned 
mixed glial culture media supplemented with various OL 
survival factors (see “Methods” for details). The purpose 
of this media was to favor the maintenance of OPCs in a 
precursor state, as migration generally ceases in differen-
tiated OLs. We also aimed to control OPC proliferation 
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by including aphidicolin (mitotic inhibitor) in the migra-
tion media, as excessive proliferation could give the false 
impression of extensive migration.
When seeded onto laminin-coated coverslips, large 
numbers of cells migrated out of OPCAs over a 24  h 
period (Fig.  2a). After a given experimental duration 
(e.g., 10  h), OPCAs were processed for immunofluores-
cence microscopy, and concentric rings (centered on 
the OPCA core) were digitally overlaid on the acquired 
images (Fig.  2b). When OPCs in each concentric ring 
were counted, distributions could be generated that 
described the net distance traveled by the cells over a 
given timeframe. Slow migration rate would cause OPCs 
to appear accumulated in rings proximal to the OPCA 
core, whereas efficient migration would increase the pro-
portion of cells in the more distal rings. This data could 
also be portrayed as the total number of migrated OPCs 
(regardless of distance), which we interpret as a measure 
of migration initiation. For example, a reduction in the 
total number of migrating OPCs subsequent to an exper-
imental manipulation could be interpreted as compro-
mised migration initiation.
To ensure that migratory cells were in fact OPCs, 
OPCAs were labeled with antibodies against the OPC 
markers platelet-derived growth factor receptor-α 
(PDGFR-α) and Olig2 (reviewed by [17]). Preliminary 
observations suggested the majority of cells were immu-
nopositive for these markers (Fig.  3a), and subsequent 
quantification revealed that 88.6 % (±0.4 %) were in fact 
Olig2+ (Fig. 3b). Our observations indicate the majority 
of cells migrating from OPCAs are of OL-lineage, thereby 
validating the utility of this assay for studying OPC 
migration.
Conditional ablation of ILK from OPCAs
Subsequent to its validation, we aimed to utilize the 
OPCA assay to investigate the role of ILK in mouse OPC 
migration. ILK is a focal adhesion protein that elicits its 
Fig. 2 Seeding OPCAs on migration‑permissive substrates yields a quantitative means to assess OPC motility. a Time‑lapse phase contrast micros‑
copy of an OPCA from which OPCs emerge radially over a 24 h period. b A 10 h migrated OPCA before (i) and after (i’) superimposing concentric 
rings (100 µm increments) over the residual OPCA core (solid white circle). Migration distance can be conveyed as the proportion of cells in each ring 
or the total number of migrated cells regardless of distance. Membrane‑targeted tdTomato (red) facilitates visualization of cell bodies. Scale bar,  
a 50 µm
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function via interaction with the integrins, a family of 
transmembrane receptors that mediate adhesion to the 
ECM. During migration, integrin receptors cluster in 
discrete foci at the leading edge of lamellipodia, forming 
cell/matrix contacts that are used as anchor points for the 
actin cytoskeleton. Integrins are heterodimers composed 
of an α and a β subunit, and OL-lineage cells express αvβ1, 
αvβ3, αvβ5, αvβ8 and α6β1 integrins inclusively [18]. ILK 
binds to the intracellular tails of β1 and β3 integrin sub-
units [19, 20], and plays both signaling and scaffolding 
roles at actin-integrin connections (Fig. 4a; [21, 22]. ILK 
performs these functions with help from binding partners 
PINCH and parvin, which respectively link ILK to recep-
tor tyrosine kinases and the actin cytoskeleton [23]. In 
OLs, ILK mediates cellular morphology by way of regu-
lating actin architecture and the activity of the cytoskel-
etal remodeling protein RhoA [24, 25]. As cellular motility 
relies on Rho-GTPase signaling, cytoskeletal dynamics 
and morphological plasticity, we hypothesized that ILK is 
required for ECM-directed OPC migration.
To this end, we employed a mutant mouse possessing 
loxP sites flanking exons 5–12 of the endogenous Ilk gene 
(Ilkfl/fl; Fig.  4b), where recombination presumably pro-
duces null alleles [15]. We then bred Ilkfl/fl;mT/mG dou-
ble transgenics by crossing Ilkfl/fl mice with the mT/mG 
strain; a reporter line harboring a locus coding for near-
ubiquitous expression of the fluorescent protein tdTo-
mato [16]. The action of Cre recombinase at this locus 
ablates tdTomato, while at the same time inducing EGFP 
(Fig. 4c), thereby permitting identification of Cre-recom-
bined cells. Therefore, recombined cells should express 
EGFP and be devoid of ILK, while non-recombined cells 
remain tdTomato+ and retain ILK expression.
Mixed glial cultures were then established from Ilkfl/
fl;mT/mG mice and treated with cell-permeable TAT-
Cre recombinase or vehicle control (see “Methods” for 
details). As expected, TAT-Cre administration led to a 
reduction in total ILK protein in Ilkfl/fl;mT/mG cultures 
as compared with vehicle-treated controls (Fig.  4d). We 
then isolated OPCAs from TAT-Cre treated cultures 
and allowed OPCs to migrate outwards for 10  h. Cre-
recombined OPCs could be identified by their expression 
of EGFP, although non-recombined (tdTomato+) OPCs 
were still a significant component of the TAT-Cre treated 
OPCA (Fig. 4e). In sum, our work shows that the OPCA 
assay can be used in conjunction with conditional knock-
out genetics, and we next aimed to utilize this strategy to 
investigate the role of ILK in OPC migration.
Loss of ILK mildly impairs OPC migration on laminin
Merosin, a blanket term for α2-chain containing laminin 
(Ln) proteins (Ln-2, Ln-4 and Ln-13; [26] influences 
various aspects of OL biology including growth factor-
mediated survival [27, 28], morphological development 
[29], and CNS myelination [24]. Notably, myelinating 
CNS white matter tracts express the Ln α2-chain [30, 31], 
which is also upregulated after experimentally induced 
demyelination [32]; reviewed by [33]. In addition, Ln 
promotes OPC migration [34–36], rendering Ln signal-
ing pathways appealing pharmacological targets for over-
coming the inhibitory barriers impeding OPC infiltration 
into MS lesions.
Ln binds the α6β1 integrin expressed by OLs [29], trig-
gering ILK recruitment to β1-cytosolic tails [23], yielding 
Ln-α6β1-ILK complexes to which the actin cytoskeleton 
is stabilized. These adhesions presumably act as ECM 
anchor points that transmit cytoskeletal contractile forces 
during cellular migration. We therefore hypothesized that 
ILK loss would impede OPC migration on Ln due to actin-
integrin disassociation. To this end, TAT-Cre treated and 
vehicle treated Ilkfl/fl;mT/mG OPCAs (henceforth referred 
to as Ilk−/− and Ilkfl/fl OPCAs respectively) were seeded 
onto Ln substrates, allowing migration to occur for 4, 10 
and 24 h. Using concentric ring quantification, we found 
that ILK loss caused an accumulation of OPCs in the 
50 μm proximal ring after 4 h compared to Ilkfl/fl OPCAs. 
Additionally, there was a corresponding decrease in the 
proportion of Ilk−/− OPCs that had attained the more dis-
tal 100 μm ring, ultimately indicating a reduction in net 
migration distance (Fig.  5a, b). Interestingly, this deficit 
was not evident at 10 or 24 h. There was also a near-signif-
icant trend for fewer total migrated Ilk−/− OPCs at the 4 h 
time point (p = 0.0675; Fig. 5c), an indication of reduced 
capacity to initiate migration. Importantly, there was 
no difference between the diameters of Ilk−/− and Ilkfl/
fl OPCAs at seeding, discounting size as a confounding 
Fig. 3 OPCAs are predominantly composed of OPCs. a 10 h migrated 
OPCAs showing the majority of migratory cells are positive for the 
OPC markers PDGFR‑α and Olig2. b OPCAs are composed of on 
average 88.6 % (±0.4 %) Olig2+ cells. Data represent the mean ± SEM 
(n = 3). Scale bars, a 50 and 20 µm (inset)
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variable in our observations (Fig.  5d). Rather, we attrib-
ute our findings to a role for ILK in the initiation and/or 
maintenance of migration on Ln.
ILK loss severely disrupts OPC migration on fibronectin
Fibronectin (Fn) is a migration-permissive substrate for 
OPCs [34, 37], but evidence suggests that Fn aggregation 
Fig. 4 Conditional genetic ablation of Ilk from OPCAs. a ILK is a focal contact protein that links ECM‑bound integrin receptors to the actin cytoskel‑
eton via its partner parvin. In the depiction, α6β1 and αvβ3 integrin receptors reside at the leading edge of a migrating OPC’s process, where they 
respectively bind laminin (Ln) and fibronectin (Fn). At the β‑integrin cytosolic tails, ILK stabilizes ECM adhesions to the actin cytoskeleton (red circles) 
by acting as a scaffold. b Schematic representation of the mouse Ilkfl/fl locus, where Cre recombination excises exons 5–12 of the Ilk gene [15].  
c Schematic representation of the mT/mG reporter locus [16]. Cre‑recombination at the LoxP sites excises tdTomato and induces EGFP expression. 
d Western blot showing TAT‑Cre reduces ILK protein when administered to Ilkfl/fl;mT/mG cultures. Significant difference confirmed by densitomet‑
ric analysis. e OPCAs isolated from TAT‑Cre treated Ilkfl/fl;mT/mG cultures, showing they are composed of both recombined (EGFP‑positive) and 
non‑recombined (tdTomato‑positive) OPCs. Presumably, ILK is depleted from OPCs expressing EGFP. For d, data represent the mean ± SEM (n = 3), 
*p < 0.05 (Student’s t test). Scale bar, 50 μm
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impedes remyelination in MS [38]. This underscores 
the importance of elucidating the signaling pathways 
that govern OPC migration on Fn, as their pharmaco-
logical manipulation may influence the degree to which 
OPCs infiltrate MS lesions. OL-lineage cells express the 
αvβ1, αvβ3, αvβ5 and αvβ8 integrin receptors which recog-
nize the Arg-Gly-Asp (RGD) integrin binding sequence 
intrinsic to Fn and other ECM molecules [37, 39]. As 
ILK is recruited to β1 and β3 integrin tails to stabilize 
actin at cell–matrix contacts, we hypothesized that ILK-
depleted OPCs would suffer from defective migration on 
Fn substrates.
Ilk−/− and Ilkfl/fl OPCAs were seeded onto Fn-coated 
coverslips, and migration was assessed after 4, 10 
and 24  h. In contrast to migration on Ln, there was no 
substantial OPC migration of either genotype on Fn at 
4 h. Not surprisingly then, we noted no migration differ-
ences between Ilk−/− and Ilkfl/fl OPCs at this time point 
(Fig. 6a, b). Rather, we observed significantly reduced net 
migration distance of Ilk−/− OPCs at 10 and 24 h. At 10 h, 
Ilk−/− OPCs accumulated in the most proximal concen-
tric ring (40 μm), with correspondingly fewer cells reach-
ing the more distal ring (80 μm), a defect that persisted at 
24 h. The total number of migrated Ilk−/− OPCs was also 
significantly reduced at 10 and 24 h (Fig. 6c), implying a 
role for ILK in initiating migration on Fn. We observed 
no significant difference in the size of Ilkfl/fl and Ilk−/− 
OPCAs at seeding time (Fig. 6e), excluding OPCA size as 
a factor in our analysis. Our data suggest OPC migration 
on Fn relies heavily on ILK, as its loss compromises both 
Fig. 5 Transient impairment of OPC migration on laminin in response to ILK loss. a Representative confocal images of Ilk−/− and Ilkfl/fl OPCAs 
migrated on Ln for 4, 10 and 24 h. b Quantification of OPC migration using the concentric ring method (see “Methods” section). At the 4 h time 
point, Ilk−/− OPCs accumulated in the most proximal concentric ring (50 μm) and fewer attained the more distant 100 μm ring as compared to  
Ilkfl/fl control cells. Interestingly however, Ilk−/− and Ilkfl/fl OPCs migrated to the same extent at the 10 and 24 h time points. c No significant dif‑
ference between the total number of migrated Ilk−/− and Ilkfl/fl OPCs was found at any time point. d There was no significant difference in initial 
diameter of Ilk−/− and Ilkfl/fl OPCAs. Data represent the mean ± SEM (n = 5, 5 and 4 for the 4, 10 and 24 h time points, respectively). For b, *p < 0.05; 
****p < 0.0001 (repeated measures two‑way ANOVA followed by Bonferroni post‑tests). For c and d, data was tested with Student’s t test. Scale bars, 
50, 100 and 200 μm for 4, 10 and 24 h time points, respectively
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net migration distance and the initiation of migration 
itself.
ILK is required for OPC migration on polylysine matrix
Poly-d-lysine (PDL) is a molecule that carries a net posi-
tive charge and interacts with anionic cell membrane 
domains to mediate adhesion [40]. While polylysine itself 
does not mediate cell adhesion via the integrins [41], it 
can promote the deposition of cell culture media-borne 
proteins [42], some of which may activate integrins to 
regulate migration. PDL can be thought of as a substrate 
that provides both a non-specific charge-based affinity 
for cells, and one that facilitates veritable receptor-ligand 
interactions.
When migrated on PDL, Ilk−/− OPCs accumulated 
more so in the most proximal concentric rings at the 4, 10 
and 24 h time points as compared to Ilkfl/fl cells (Fig. 7a, 
b). ILK depletion also yielded fewer total migrated OPCs 
at 4 h, although no significant difference was observed at 
10 and 24  h (Fig.  7c). This early lag in emergence from 
the OPCA offers a role for ILK in the initiation of OPC 
migration on PDL, which does not persist at later time 
points. Importantly, no difference was observed in the 
initial OPCA diameters between genotypes (Fig.  7d), 
excluding size as a confounding factor in our analysis. 
Instead, our data support an intriguing function for ILK 
in the initiation and maintenance of OPC migration on a 
substrate that likely possesses a mixture of signaling cues.
Fig. 6 Loss of ILK perturbs OPC migration on fibronectin substrate. a Confocal micrographs of Ilkfl/fl and Ilk−/− OPCAs migrated on Fn for 4, 10 and 
24 h. b Quantification revealed no difference in the distance migrated between Ilk−/− and Ilkfl/fl populations at 4 h. However, at 10 h, Ilk−/− OPCs 
predominantly migrated to the 40 μm proximal ring, and fewer reached the more distant 80 μm ring as compared to Ilkfl/fl cells. Similarly, at 24 h, 
Ilk−/− OPCs accumulated in the 80 μm proximal ring, with fewer attaining the more distal 160 μm ring. c There was no difference in the total num‑
ber of migrated Ilk−/− and Ilkfl/fl OPCs at 4 h, while significantly fewer Ilk−/− OPCs had migrated at the 10 and 24 h time points. d The initial diameter 
of Ilk−/− and Ilkfl/fl OPCAs prior to assay commencement was not significantly different for any of the time intervals investigated. Data represent the 
mean ± SEM (n = 3). For b, *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 (repeated measures two‑way ANOVA followed by Bonferroni post‑
tests). For c and d, *p < 0.05 (Student’s t test). Scale bars, 50 μm for 4 h, 100 μm for 10 and 24 h
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Discussion
In this report, we demonstrate a role for ILK in OPC 
migration by utilizing a newly developed method tai-
lored for mouse-derived cells. We show ILK regulates 
OPC migration on Ln and Fn, two ECM proteins pre-
sent in demyelinated lesions [32, 38] as well as on a 
polylysine matrix. Impaired OPC infiltration into MS 
lesions is thought to partly underlie the lack of regen-
eration seen in chronic MS, emphasizing the need to 
understand the mechanics governing OPC migration, 
especially when pursuing remyelination therapies. 
Our work contributes to this increasing understand-
ing, while also providing a new tool for investigating 
OPC migration that is amenable to both constitutive 
and conditional knockout/transgenic mouse lines.
An assay to study mouse OPC migration in vitro
The use of mouse OPCs in basic research is becom-
ing increasingly popular, a trend surely reflecting the 
accessibility of mutant lines and technological advance-
ments in their generation. However, when compared to 
rat-sourced cells, the utility of mouse OPCs is limited as 
they are more difficult to isolate [7] and do not survive 
as well in culture [8]. This imposes constraints on the 
commonly used “agarose drop” and “transwell” migration 
assays, emphasizing the need for methods that account 
for the shortcomings of mouse OPCs. We estimate that 
an OPCA is composed of approximately 300-1000 cells, 
and a typical preparation yields roughly 50–100 OPCAs. 
Additionally, migration can be measured in as little as 
4 h rather than several days, as is the case for the agarose 
Fig. 7 ILK mediates OPC migration on PDL. a Confocal images of Ilk−/− and Ilkfl/fl OPCAs migrated on PDL for 4, 10 and 24 h. b As compared to  
Ilkfl/fl OPCs, Ilk−/− OPCs were more concentrated in the 10, 20 and 40 μm proximal concentric rings at 4, 10 and 24 h respectively. c No difference in 
the total number of migrated Ilk−/− versus Ilkfl/fl OPCs was observed at 10 or 24 h, although significantly fewer Ilk−/− OPCs had migrated at the 4 h 
time point. d There was no difference in the diameters of Ilk−/− versus Ilkfl/fl OPCAs prior to commencement of the assay for any of the time points 
assessed. Data represent the mean ± SEM (n = 4). For b, **p < 0.01; ***p < 0.001 (repeated measures two‑way ANOVA followed by Bonferroni post‑
tests). For c and d, **p < 0.01 (Student’s t test). Scale bars, 50 μm
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drop assay. Our assay therefore accommodates the limi-
tations of mouse OPCs by calling for few cells and requir-
ing relatively short assay durations.
Our method bears resemblance to the “oligosphere” 
assay, originally described by [5]. In this method, rat 
OPCs are purified using a Percoll gradient, and seeded 
onto uncoated tissue culture vessels. Over several days, 
suspended OPCs form spherical aggregates reminiscent 
of neurospheres, while their OL identity is maintained 
through use of N1 supplemented B104-conditioned 
media. When seeded onto polyornithine substrates, 
OPCs emerge from oligospheres in a radial fashion as 
in our OPCA assay. This method has been applied to 
elegantly demonstrate that polysialylation of neural cell 
adhesion molecule (PSA-NCAM) favours OPC migra-
tion [43], and been leveraged to identify the importance 
of metalloproteases in OPC migration on CNS matrices 
[44]. To modify the assay for use with mouse cells, [11] 
increased the concentration of insulin and progesterone 
in the oligosphere culture media to enhance OPC prolif-
eration and/or ameliorate viability [11].
One major benefit of the OPCA assay over the oligo-
sphere method is that aggregate generation requires less 
researcher manipulation. To generate OPC aggregates in 
the OPCA assay, mixed glial cultures are simply shaken 
on an orbital rotator overnight in a tissue culture incu-
bator. To generate oligospheres however, multiple 18  h 
differential adhesion steps need be conducted [5]. Our 
method also describes an efficient means to conditionally 
ablate/modify genes using LoxP technology, which is of 
high value when investigating genes whose constitutive 
loss leads to embryonic lethality.
Another feature of the OPCA method is its potential 
use in live cell imaging, facilitating the observation of 
OPC migration in real-time. In our hands however, we 
have experienced phototoxicity as a result of visualizing 
fluorescent proteins (e.g., EGFP, tdTomato) in live OPCs 
(data not shown). In addition, live imaging may not be 
suitable when assessing the effect of photosensitive com-
pounds on OPC migration.
ILK in OPC migration on various substrates
Interactions between the ECM and OL-bound integ-
rin receptors govern numerous aspects of OL biology 
(reviewed by [9]. OPCs express the α6β1 integrin Ln 
receptor along with the αvβ1 and αvβ3 integrin Fn recep-
tors [18], to which ILK binds at β1 and β3 cytoplasmic 
tails [19, 20]. The impaired migration of Ilk−/− OPCs on 
Ln and Fn matrices likely results from perturbed stability 
of connections between the ECM and the actin cytoskele-
ton (Fig. 4a). Disrupting these adhesion complexes would 
likely translate to difficulty stabilizing a leading process, 
and compromise the cell’s ability to utilize focal contacts 
to transduce cytoskeletal contractile forces required for 
migration.
Interestingly, ILK loss produced only a mild deficit in 
OPC motility on Ln, in that migration was lagging at 
4 h, but had recovered at the 10 and 24 h time points. As 
ILK stabilizes α6β1 integrins on Ln, our findings are in 
agreement with previous studies showing a role for α6β1 
integrin only during the early phases of OPC migration 
[39], with no significant contribution in the long term 
[37]. These data insinuate a more significant role for α6β1 
integrin in other aspects of OL biology, as it is the major 
β1-type receptor expressed by OLs, and is consistently 
expressed throughout OL development [18]. Accordingly, 
extension of OL myelin membrane [29], and CNS myeli-
nation [45, 46] are regulated by Ln-α6β1 integrin inter-
actions, while similar functions have been identified for 
ILK [24, 25]. The Ln-α6β1-ILK complex may therefore be 
more relevant in post-migratory OL development, while 
only mildly contributing to Ln-directed motility. The 
observation that efficient migration still occurred on Ln 
in the absence of ILK suggests alternate signaling mecha-
nisms predominantly drive migration on this substrate.
We offer the possibility that OPCs express additional, 
ILK-independent receptors that contribute to OPC 
migration on Ln. Existence of such receptors could 
explain how Ilk−/− OPCs are only mildly incapacitated in 
their migration on Ln, and ultimately travel to the same 
degree as control cells. One candidate is dystroglycan, a 
Ln binding protein expressed by OL-lineage cells [47], 
with a function in OL process outgrowth [48]. Dystrogly-
can localizes to OL adhesion contact sites, and co-precip-
itates with focal adhesion kinase [48]. Recent work has 
also shown that nestin-Cre driven deletion of dystrogly-
can negatively impacts cerebellar granule neuron migra-
tion [49], offering a parallel function for dystroglycan 
in OPCs, as neurons and OLs share much of the same 
migratory mechanisms [50]. The role of dystroglycan 
(and/or other Ln adhesion molecules) in OPC migration 
remains an open question for investigation, and may pro-
vide an explanation for the migration-permissive charac-
ter of Ln.
In contrast to Ln, for which α6β1 is the exclusive inte-
grin receptor, OPCs express the Fn-sensitive αvβ1, αvβ3, 
αvβ5 and αvβ8 integrins [18]. With regard to our work, 
αvβ3 and αvβ1 are most relevant, as ILK exclusively binds 
β1 and β3 cytosolic tails [19, 20]. [39] previously demon-
strated a role for αvβ3 in OPC migration on Fn, while, in 
contrast, αvβ1 was determined dispensable. A role for 
β1 integrin in OPC migration on Fn was suggested by 
Tiwari-Woodruff and colleagues in 2001, although in 
their study, migration was assessed after 4 days in vitro, a 
point at which OPC proliferation may confound observa-
tions. Rather, in line with [39], we favor the concept that 
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the migratory phenotype manifested by Ilk−/− OPCs on 
Fn is primarily a product of perturbed signaling/stability 
at Fn-αvβ3-actin connections. Importantly, this does not 
discount a role for αvβ1 integrin in OPC migration in a 
broader context, as this receptor significantly mediates 
OPC migration on astrocyte-produced ECM [37], a sub-
strate surely composed of various integrin ligands. Ilk−/− 
OPCs were not completely ablated in their ability to 
migrate on Fn, suggesting that receptors other than αvβ3 
and αvβ1 may be at play. Of note, [39] previously found 
no role for αvβ5 in OPC migration on Fn, leaving the less-
characterized αvβ8 integrin receptor with a possible func-
tion in this process [37].
In contrast to Ln and Fn that bind specific receptors 
on the cell surface, the adhesion of cells to PDL is medi-
ated by charge interactions between anionic membrane 
domains and the positively charged nature of polyly-
sine [40]. Polylysine is not thought to engage integrins, 
although it is capable of binding ECM proteins present 
in cell culture media [42]. We propose the impaired 
migration of Ilk−/− OPCs on PDL is a result of this latter 
phenomenon, where ILK-devoid cells are compromised 
in their ability to engage PDL-immobilized ligands con-
tributed by the media. Fetal bovine serum, which makes 
up 10 % of our migration media, is known to contain the 
ECM protein vitronectin. Similar to Fn, vitronectin also 
possesses the arginine-glycine-aspartic acid (RGD) motif 
recognized by many integrin receptors [51]. In fact, vit-
ronectin is believed to be the major cell-attachment pro-
tein present in fetal bovine serum [52]. OLs express αvβ1, 
αvβ3, αvβ5 and αvβ8 integrins, which all possess affinity for 
vitronectin [53–56]. As ILK only binds β1 and β3 integ-
rins, we can speculate that defective migration of Ilk−/− 
OPCs on PDL is caused partly by the reduced stability of 
αvβ1, αvβ3 integrin adhesions responsible for stabilizing 
connections between vitronectin and the cytoskeleton.
Cell signaling in OPC migration and relevance to MS 
therapy development
Oligodendrocyte precursor cells (OPCs) migrate exten-
sively prior to the onset of central nervous system (CNS) 
myelination [57] a process governed in part by the extra-
cellular matrix (ECM) during both normal development 
and remyelination of demyelinated lesions [58]. Endog-
enous lesion repair in MS decreases with disease pro-
gression, a consequence of reduced OPC proliferation, 
differentiation and/or migration [3]. Of note, OPCs accu-
mulate at the periphery of early MS lesions [59], which is 
thought to be a result of lesion-derived inhibitory factors 
impeding OPC recruitment inwards [60–64]. Elucidating 
the molecular mechanisms that govern OPC migration 
will therefore facilitate the design of therapeutics aimed 
at promoting OPC infiltration into MS lesions.
We have previously shown that ILK-devoid OLs pos-
sess elevated RhoA activity, a phenomenon associated 
with a disorganized actin cytoskeleton [25]. This obser-
vation agrees with previous work from other cell sys-
tems [65, 66]; reviewed by [21, 22], where ILK loss leads 
to an upregulation in RhoA activity, while concomi-
tantly reducing cell–matrix adhesions [67]. Conversely, 
reducing RhoA activity promotes reorganization of 
focal contacts [68], and diminishes actomyosin con-
tractility to facilitate migration (reviewed by [69]. It 
is quite likely then, that an ideal level of RhoA activity 
exists that promotes persistent directional migration 
when properly localized subcellularly. In such a case, 
localized RhoA activity would promote cell migration 
by preventing the extension of numerous leading lamel-
lipodia, ensuring focal contacts remain dynamic and by 
controlling the cleavage of trailing-edge adhesions. If 
Ilk−/− OPCs do suffer from elevated RhoA activity, the 
dysregulation of these cellular processes could explain 
their compromised migratory capacity. While we did 
not test this hypothesis, it is an intriguing direction for 
future research.
The RhoA signaling axis is becoming of increasing 
interest with regard to MS therapeutics. Other proteins 
such as Netrin-1, Slit2 and NG2 mediate OPC migration 
through modulation of RhoA signaling [70–72]. RhoA 
pathway downregulation by pharmacological means 
enhances morphological development of OL-lineage cells 
[25, 73, 74], even in the presence of OL-inhibitory fac-
tors [75, 76]. Blockade of LINGO-1, an upstream regu-
lator of RhoA (reviewed by [77], not only facilitates OL 
differentiation in vitro [78] but also enhances remyelina-
tion in vivo [79]. As multiple signaling pathways converge 
on RhoA to regulate OL biology, as well as the fact that 
RhoA-ROCK pathway inhibitors are currently in use 
for other CNS ailments [80], their efficacy in promoting 
remyelination in MS disease models remains an appeal-
ing direction for future investigation.
Conclusions
Here, we present a new OPC migration assay tailored 
specifically for use with mouse-derived cells, which we 
name the OPCA assay. OPCAs are highly enriched for 
OPCs, and when seeded onto Ln, Fn or polylysine, rapid 
outward migration occurs. We further show that the 
OPCA method is amenable to conditional gene abla-
tion through use of TAT-Cre recombinase to deplete 
ILK from OPCAs generated from Ilkfl/fl mice. ILK-devoid 
OPCs were heavily impaired at migrating on Fn or pol-
ylysine matrices, while only mildly delayed in their migra-
tion on Ln. Inclusively, our work identifies ILK as a player 
in OPC migration, and provides a new tool for the study 
of mouse OPC motility in vitro.
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